From Eliot Forster, MedCity’s Executive Chair
This slightly delayed newsletter comes to you following a packed visit to BioJapan by MedCity, where we were joined by some exciting SMEs, pre-eminent scientists, experts, business leaders and, not least, the Mayor of London, to highlight the region’s excellence in cell and regenerative medicine.
Jetlag notwithstanding, our visit was a huge success and, with the Mayor’s help, created a real buzz and high levels of interest in our region. Japan is the second largest investor in the life sciences sector in the greater south east, second only to the USA, so this was an invaluable opportunity to demonstrate our talent in the field of cell and regenerative medicine, an area that is a major priority for R&D and commercialisation within Japan. You can read all about our visit below.
On a different subject, we now have a new website, launched just in advance of our visit to Japan: medcityhq.com. We are still in a period of development so your feedback would be extremely valuable – please tell us what you think at firstname.lastname@example.org